Page 70 - Read Online

Page 24 of 29 Novati et al. Ageing Neur Dis 2022;2:17 https://dx.doi.org/10.20517/and.2022.19

expression and cognitive function in a rat model of Alzheimer disease. Cereb Cortex 2017;27:1501-11. DOI PubMed PMC
147. Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR. Detecting dementia: novel neuropsychological markers
of preclinical Alzheimer’s disease. Dement Geriatr Cogn Disord 2004;17:42-8. DOI PubMed
148. Wolinsky D, Drake K, Bostwick J. Diagnosis and management of neuropsychiatric symptoms in Alzheimer’s disease. Curr
Psychiatry Rep 2018;20:117. DOI PubMed
149. Cortés N, Andrade V, Maccioni RB. Behavioral and neuropsychiatric disorders in Alzheimer’s disease. J Alzheimers Dis
2018;63:899-910. DOI PubMed
150. Morgese MG, Trabace L. Monoaminergic system modulation in depression and Alzheimer’s disease: A New Standpoint? Front
Pharmacol 2019;10:483. DOI PubMed PMC
151. Sawyer K, Corsentino E, Sachs-Ericsson N, Steffens DC. Depression, hippocampal volume changes, and cognitive decline in a
clinical sample of older depressed outpatients and non-depressed controls. Aging Ment Health 2012;16:753-62. DOI PubMed PMC
152. Selles MC, Oliveira MM, Ferreira ST. Brain inflammation connects cognitive and non-cognitive symptoms in Alzheimer’s disease. J
Alzheimers Dis 2018;64:S313-27. DOI PubMed
153. Pentkowski NS, Berkowitz LE, Thompson SM, Drake EN, Olguin CR, Clark BJ. Anxiety-like behavior as an early endophenotype in
the TgF344-AD rat model of Alzheimer’s disease. Neurobiol Aging 2018;61:169-76. DOI PubMed PMC
154. Yang L, Wu C, Tucker L, et al. Photobiomodulation therapy attenuates anxious-depressive-like behavior in the TgF344 rat model. J
Alzheimers Dis 2021;83:1415-29. DOI PubMed
155. Eikelboom WS, Pan M, Ossenkoppele R, et al. Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a
meta-analysis. Alzheimers Res Ther 2022;14:48. DOI PubMed PMC
156. Chi S, Yu JT, Tan MS, Tan L. Depression in Alzheimer’s disease: epidemiology, mechanisms, and management. J Alzheimers Dis
2014;42:739-55. DOI PubMed
157. Kosel F, Pelley JMS, Franklin TB. Behavioural and psychological symptoms of dementia in mouse models of Alzheimer’s disease-
related pathology. Neurosci Biobehav Rev 2020;112:634-47. DOI PubMed
158. Pardossi-Piquard R, Lauritzen I, Bauer C, Sacco G, Robert P, Checler F. Influence of genetic background on apathy-like behavior in
triple transgenic AD mice. Curr Alzheimer Res 2016;13:942-9. DOI PubMed
159. Hailwood JM, Heath CJ, Robbins TW, Saksida LM, Bussey TJ. Validation and optimisation of a touchscreen progressive ratio test of
motivation in male rats. Psychopharmacology (Berl) 2018;235:2739-53. DOI PubMed PMC
160. Järvenpää JP, Kopanitsa MV, Miszczuk D, Oksman J, Puoliväli J. P3-082: faster responding of Tg2576 mice in the touch screen
version of the progressive ratio task. Alzheimers Dement 2019;15:957. DOI
161. Kreuzer M, Keating GL, Fenzl T, et al. Sleep/wake behavior and EEG signatures of the TgF344-AD rat model at the prodromal stage.
Int J Mol Sci 2020;21:9290. DOI PubMed PMC
162. Iakovakis D, Chaudhuri KR, Klingelhoefer L, et al. Screening of Parkinsonian subtle fine-motor impairment from touchscreen typing
via deep learning. Sci Rep 2020;10:12623. DOI PubMed PMC
163. Park JH, Kang YJ, Horak FB. What is wrong with balance in Parkinson’s disease? J Mov Disord 2015;8:109-14. DOI PubMed
PMC
164. Fasano A, Mazzoni A, Falotico E. Reaching and grasping movements in Parkinson’s disease: a review. J Parkinsons Dis
2022;12:1083-113. DOI PubMed PMC
165. de Haas R, Heltzel LCMW, Tax D, et al. To be or not to be pink(1): contradictory findings in an animal model for Parkinson’s
disease. Brain Commun 2019;1:fcz016. DOI PubMed PMC
166. Giangrasso DM, Furlong TM, Keefe KA. Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out
rat model of Parkinson’s disease. Neurobiol Dis 2020;134:104673. DOI PubMed
167. Kyser TL, Dourson AJ, McGuire JL, Hemmerle AM, Williams MT, Seroogy KB. Characterization of motor and non-motor
behavioral alterations in the Dj-1 (PARK7) knockout rat. J Mol Neurosci 2019;69:298-311. DOI PubMed
168. Vazquez-Mayorga E, Grigoruta M, Dagda R, Martinez B, Dagda RK. Intraperitoneal administration of forskolin reverses motor
symptoms and loss of midbrain dopamine neurons in PINK1 knockout rats. J Parkinsons Dis 2022;12:831-50. DOI PubMed PMC
169. Marquis JM, Lettenberger SE, Kelm-Nelson CA. Early-onset Parkinsonian behaviors in female Pink1-/- rats. Behav Brain Res
2020;377:112175. DOI PubMed PMC
170. Kohl Z, Ben Abdallah N, Vogelgsang J, et al. Severely impaired hippocampal neurogenesis associates with an early serotonergic
deficit in a BAC α-synuclein transgenic rat model of Parkinson’s disease. Neurobiol Dis 2016;85:206-17. DOI PubMed PMC
171. Timotius IK, Moceri S, Plank AC, et al. Silhouette-length-scaled gait parameters for motor functional analysis in mice and rats.
eNeuro 2019;6:ENEURO. DOI PubMed PMC
172. Bova A, Kernodle K, Mulligan K, Leventhal D. Automated rat single-pellet reaching with 3-dimensional reconstruction of paw and
digit trajectories. J Vis Exp 2019. DOI PubMed PMC
173. Klein A, Dunnett SB. Analysis of skilled forelimb movement in rats: the single pellet reaching test and staircase test. Curr Protoc
Neurosci 2012;Chapter 8:Unit8.28. DOI PubMed
174. Dashtipour K, Tafreshi A, Lee J, Crawley B. Speech disorders in Parkinson’s disease: pathophysiology, medical management and
surgical approaches. Neurodegener Dis Manag 2018;8:337-48. DOI PubMed
175. Simons JA. Swallowing dysfunctions in Parkinson’s disease. Nonmotor Parkinson’s: the hidden face - management and the hidden
face of related disorders. Elsevier; 2017. p. 1207-38. DOI PubMed